{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:27:16Z","timestamp":1765279636340},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,12,22]],"date-time":"2007-12-22T00:00:00Z","timestamp":1198281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1245\/s10434-007-9718-8","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T17:05:36Z","timestamp":1198256736000},"page":"1407-1413","source":"Crossref","is-referenced-by-count":44,"title":["Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy"],"prefix":"10.1245","volume":"15","author":[{"given":"Lawrence E.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarette","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Pliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracie","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,22]]},"reference":[{"key":"9718_CR1","volume-title":"Principles and Practices of Oncology Updates, Vol. 9","author":"HR BJ Alexander","year":"1995","unstructured":"Alexander HR BJ, Fraker DL. Rationale and clinical status of continuous hyperthermic peritoneal perfusion for the treatment of peritoneal carcinomatosis. In: DeVita VHS, Rosenberg S (ed.) Principles and Practices of Oncology Updates, Vol. 9. Philadelphia: JB Lippincott, 1995"},{"key":"9718_CR2","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737\u201343","journal-title":"J Clin Oncol"},{"key":"9718_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jso.20243","volume":"90","author":"TW Reichman","year":"2005","unstructured":"Reichman TW, Cracchiolo B, Sama J, et al. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma. J Surg Oncol 2005;90:51\u20136","journal-title":"J Surg Oncol"},{"key":"9718_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727\u201331","journal-title":"Ann Surg Oncol"},{"key":"9718_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000313480006600607","volume":"66","author":"BW Loggie","year":"2000","unstructured":"Loggie BW, Fleming RA, McQuellon RP, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000;66:561\u20138","journal-title":"Am Surg"},{"key":"9718_CR6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","volume":"384","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon\u2019s role. Langenbecks Arch Surg 1999;384:576\u201387","journal-title":"Langenbecks Arch Surg"},{"key":"9718_CR7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cncr.10176","volume":"94","author":"CR Rossi","year":"2002","unstructured":"Rossi CR, Foletto M, Mocellin S, et al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002;94:492\u20139","journal-title":"Cancer"},{"key":"9718_CR8","first-page":"4265","volume":"42","author":"RF Ozols","year":"1982","unstructured":"Ozols RF, Young RC, Speyer JL, et al. Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 1982;42:4265\u20139","journal-title":"Cancer Res"},{"key":"9718_CR9","first-page":"687","volume":"5","author":"A Cabanes","year":"1999","unstructured":"Cabanes A, Even-Chen S, Zimberoff J, et al. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. Clin Cancer Res 1999;5:687\u201393","journal-title":"Clin Cancer Res"},{"key":"9718_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4274(00)00201-0","volume":"116","author":"Y Sadzuka","year":"2000","unstructured":"Sadzuka Y, Hirota S, Sonobe T. Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination. Toxicol Lett 2000;116:51\u20139","journal-title":"Toxicol Lett"},{"key":"9718_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejps.2007.02.004","volume":"31","author":"P-E Colombo","year":"2007","unstructured":"Colombo P-E, Boustta M, Poujol S, et al. Biodistribution of doxorubicin-alkylated poly(l-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration. Eur J Pharm Sci 2007;31:43\u201352","journal-title":"Eur J Pharm Sci"},{"key":"9718_CR12","first-page":"2186","volume":"54","author":"SK Huang","year":"1994","unstructured":"Huang SK, Stauffer PR, Hong K, et al. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994;54:2186\u201391","journal-title":"Cancer Res"},{"key":"9718_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2006","unstructured":"Esquivel J, Sticca R, Sugarbaker PH, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 2006;14:128\u201333","journal-title":"Ann Surg Oncol"},{"key":"9718_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0731-7085(03)00300-5","volume":"33","author":"A Kummerle","year":"2003","unstructured":"Kummerle A, Krueger T, Dusmet M, et al. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements. J Pharm Biomed Anal 2003;33:475\u201394","journal-title":"J Pharm Biomed Anal"},{"key":"9718_CR15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/jnci\/57.5.1063","volume":"57","author":"GM Hahn","year":"1976","unstructured":"Hahn GM, Strande DP. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 1976;57:1063\u20137","journal-title":"J Natl Cancer Inst"},{"key":"9718_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/02656739409009335","volume":"10","author":"RC Miller","year":"1994","unstructured":"Miller RC, Richards M, Baird C, et al. Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential. Int J Hyperthermia 1994;10:89\u201399","journal-title":"Int J Hyperthermia"},{"key":"9718_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","volume":"43","author":"B Hildebrandt","year":"2002","unstructured":"Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol-Hematol 2002;43:33\u201356","journal-title":"Crit Rev Oncol-Hematol"},{"key":"9718_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","volume":"92","author":"D Elias","year":"2001","unstructured":"Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71\u20136","journal-title":"Cancer"},{"key":"9718_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archsurg.138.1.26","volume":"138","author":"P Shen","year":"2003","unstructured":"Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138:26\u201333","journal-title":"Arch Surg"},{"key":"9718_CR20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(03)01074-X","volume":"4","author":"M Markman","year":"2003","unstructured":"Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol 2003;4:277\u201383","journal-title":"Lancet Oncol"},{"key":"9718_CR21","first-page":"6774","volume":"52","author":"SK Huang","year":"1992","unstructured":"Huang SK, Mayhew E, Gilani S, et al. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 1992;52:6774\u201381","journal-title":"Cancer Res"},{"key":"9718_CR22","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","volume":"88","author":"D Papahadjopoulos","year":"1991","unstructured":"Papahadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 1991;88:11460\u20134","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9718_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0360-3016(94)90572-X","volume":"29","author":"S Ning","year":"1994","unstructured":"Ning S, Macleod K, Abra RM, et al. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Radiat Oncol Biol Phys 1994;29:827\u201334","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9718_CR24","first-page":"6950","volume":"60","author":"G Kong","year":"2000","unstructured":"Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000;60:6950\u20137","journal-title":"Cancer Res"},{"key":"9718_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/bjs.4473","volume":"91","author":"O Glehen","year":"2004","unstructured":"Glehen O, Cotte E, Schreiber V, et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Brit J Surg 2004;91:747\u201354","journal-title":"Brit J Surg"},{"key":"9718_CR26","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T","volume":"77","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622\u20139","journal-title":"Cancer"},{"key":"9718_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z","volume":"89","author":"O Lyass","year":"2000","unstructured":"Lyass O, Uziely B, Ben-Yosef R, et al. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer 2000;89:1037\u201347","journal-title":"Cancer"},{"key":"9718_CR28","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1995.13.7.1777","volume":"13","author":"B Uziely","year":"1995","unstructured":"Uziely B, Jeffers S, Isacson R, et al. Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 1995;13:1777\u201385","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9718-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9718-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:11:10Z","timestamp":1684152670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9718-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,22]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["9718"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9718-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,22]]}}}